Triamcinolone Acetonide Ointment USP 0.5% Recalled by Teligent Pharma
Teligent Pharma is recalling Triamcinolone Acetonide Ointment USP 0.5% due to current good manufacturing practice (cGMP) deviations. The firm has discontinued its stability study program, affecting approximately 159,994 tubes distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text indicates cGMP deviations related to discontinuation of stability testing, which is a manufacturing/compliance issue. No illnesses, injuries, or product quality failures are reported in the source text, making this a precautionary recall based on process deficiency rather than demonstrated harm.
Plain-English summary
Teligent Pharma, Inc. is recalling Triamcinolone Acetonide Ointment USP, 0.5% (15 gram tubes, NDC 52565-048-15) due to cGMP deviations. All products within expiry date are included in the recall because the firm is discontinuing its stability study program.
The recalled product was distributed nationwide in the USA and Puerto Rico. Approximately 159,994 tubes are affected across three batches: Batch 15608 (Exp. 5/31/2022), Batch 16026 (Exp. 9/30/2022), and Batch 16224 (Exp. 11/30/2022).
Patients currently using this medication should contact their healthcare provider or pharmacist before discontinuing use. Healthcare providers and patients should report any adverse events to the FDA's MedWatch program.
The recalled product
- Product
- Triamcinolone Acetonide Ointment USP, 0.5%, Net Wt. 15 grams tube, Rx Only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-048-15.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Affected units
- 159,994
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Batch: 15608
- Exp. 5/31/2022
- 16026
- Exp. 9/30/2022
- 16224
- Exp. 11/30/2022
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14